Correlation between Glycosylated Haemoglobin and serum lipid profile in patients with type 2 diabetes
Keywords:
Diabetes mellitus, Dyslipidemia, Glycosylated hemoglobinAbstract
Introduction: Dyslipidaemia is one of the major risk factor for cardiovascular disease in Type 2 Diabetes mellitus, characterized by elevated Total cholesterol (TC), Triglycerides (TG), Low density lipoprotein (LDL) and decreased High density lipoprotein (HDL). Haemoglobin A1c (HbA1c) is widely used as an index of mean glycaemia, a measure of risk for the development of diabetes complications and a measure of the quality of diabetes care. The aim of this study was to determine the impact of glycaemic control on lipid profile and to know utility of HbA1c as an indirect indicator of dyslipidaemia. Objectives: To assess the relationship between glycemic control (HbA1c) and serum lipid profile as well as to evaluate the importance of HbA1c as an indicator of dyslipidemia in patients with T2DM. Materials and Methods: The present study is a prospective, observational study which is conducted in the Department of General Medicine at Surabhi Institute of Medical Sciences over a period of 6 months. A total of 65 T2DM patients with dyslipidemia who had visited the hospital. Inclusion criteria: Adults aged above 30 years and having Type 2 Diabetes Mellitus with dyslipidaemia.
Downloads
References
Saeed KMI, Asghar RJ, Sahak MN, et al. Prevalence and risk factors associated with diabetes mellitus among Kabul citizens— Afghanistan, 2012. Int J Diabetes Dev Ctries 2015; 35: 297–303
Tabish SA. Is diabetes becoming the biggest epidemic of the twenty-first century? Int J Health Sci 2007; 1: V–VIII.
Vinod Mahato R, Gyawali P, Raut PP, et al. Association between glycemic control and serum lipid profile in type 2 diabetic patients: glycated hemoglobin as a dual biomarker. Biomed Res 2011; 22: 375–380.
Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, et al. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes 2014; 5: 444–470.
Zahidullah M, Aasim M, Khan I, et al. Evaluation of patients with coronary artery disease for major modifiable risk factors for ischemic heart disease. J Ayub Med Coll Abbottabad 2012; 24: 102–105.
Syed I and Khan WA. Glycated hemoglobin – a marker and predictor of cardiovascular disease. J Pak Med Assoc 2011; 61: 690–695.
Dixit AK, Dey R, Suresh A, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of Ayurveda Hospital. J Diabetes Metab Disord 2014; 13: 58.
Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinal Metab 2001; 86: 965–971.
Sheth J, Shah A, Sheth F, Trivedi S, Nabar N, Shah N, et al. The association of dyslipidaemia and obesity with glycated haemoglobin. Clinical Diabetes Endocrinal. 2015; 1(1):6. 34.
Wexler DJ, Grant RW, Meigs JB, et al. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514–520.
Sibley SD, Thomas W, de Boer I, et al. Gender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesity. Am J Kidney Dis 2006; 47: 223–232.
Sultanpur C, K deepak, Kumar S: Comperhensive review on HbA1c in diagnosis of Diabetes mellitus. International journal of pharmaceutical sciences review and research. 2010;3:119-122.
Sultania, S., Thakur, D., & Kulshreshtha, M. Study of lipid profile in type 2 diabetes mellitus patients and its correlation with HbA1c. International Journal of Contemporary Medical Research, 2017;4(2), 437-439.
Balasubramanyam M, Rema M, Premanand C: Biochemical and molecular mechanisms of diabetic retinopathy. Current science. 2002;83:1056-1514.
Firdous S and Khan M. Comparison of patterns of lipid profile in type-2 diabetics and non-diabetics. Ann King Edward Med Coll 2007; 13: 84–87.
Regmi P, Gyawali P, Shrestha R, Sigdel M, Mehta KD, Majhi S. Pattern of Dyslipidemia in Type 2 Diabetic Subjects in Eastern Nepal. JNAMLS 2009; 10: 11-13.
Mahato RV, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR . Association between glycemic control and serum lipid profile in type 2 diabetic patients: Glycated hemoglobin as dual biomarker. Biomedical research 2011 : 22(3) : 375-380
Ito C, Maeda R, Ishida S, Sasaki H, Harada H. Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000; 50: 225-230.
Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, et al. Glycated hemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabetes Med 1998; 15: 573-578.
Rosediani M, Azidah AK, Mafauzy M. Correlation between fasting plasma glucose, post prandial glucose and glycated hemoglobin and fructosamine. Med J Malaysia 2006; 61: 67- 71.
Erciyas F, Taneli F, Arslan B, Uslu Y. Glycemic con-trol, oxidative stress and lipid profile in children with type 1 Diabetes Mellitus. Arch Med Res 2004; 35:134-140.
Thambiah, S. C., Intan Nureslyna Samsudin MBBCh BAO, M., Elizabeth George, M. B. B. S., Siti Yazmin Zahari Sham MD, M., Lee, H. M., Muhamad, M. A., & Hussein, Z. Relationship between dyslipidaemia and glycaemic status in patients with Type 2 diabetes mellitus. The Malaysian journal of pathology 2016;38(2), 123.
Ohta T, Nishiyama S, Nakamura T, Saku K, Maung KK, Matsuda I. Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus. Eur J Pediatr 1998; 157: 276-281.
Khan HA, Sobki SH, Khan SA. Association between glycemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidemia. Clin Exp Med 2007; 7: 24-29.
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
Powers AC .Diabetes Mellitus. In: Fauci AS, Kasper DL, Hauser SL, Longo DL, Jamenson Jl, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th edition. New York: McGraw Hill; 2012, p 2968-92.
Salman M, Dasgupta S, Souza C, Xaviour D, Raviprasad B, Rao J: Impact of Hypertension on Type 2 Diabetes in Mysore Population of South India. IJCM. 2013;4:561-570.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
